SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001645113-21-000119
Filing Date
2021-12-07
Accepted
2021-12-07 16:01:15
Documents
13
Period of Report
2021-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvcr-20211207.htm   iXBRL 8-K 34426
2 EX-99.1 pressreleaseofnovocurelimi.htm EX-99.1 9167
  Complete submission text file 0001645113-21-000119.txt   185578

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvcr-20211207.xsd EX-101.SCH 1999
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvcr-20211207_lab.xml EX-101.LAB 24053
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvcr-20211207_pre.xml EX-101.PRE 12577
6 EXTRACTED XBRL INSTANCE DOCUMENT nvcr-20211207_htm.xml XML 11140
Mailing Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF
Business Address NO. 4 THE FORUM GRENVILLE STREET ST. HELIER Y9 JE2 4UF 44 (0)15 3475 6700
NovoCure Ltd (Filer) CIK: 0001645113 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37565 | Film No.: 211475967
SIC: 3841 Surgical & Medical Instruments & Apparatus